Villar Hugo E, Jugo Mónica B, Macan Alejandro, Visser Matias, Hidalgo Mariana, Maccallini Gustavo Cesar
Laboratorio Hidalgo, Buenos Aires, Argentina.
J Infect Dev Ctries. 2014 Jun 11;8(6):699-704. doi: 10.3855/jidc.3766.
Knowledge of the etiology and antimicrobial susceptibility patterns of uropathogens is important for determining the best treatment option. This study aimed to determine the distribution and antibiotic susceptibility patterns of bacterial strains isolated from adult male outpatients.
Between November 2012 and April 2013, 3,105 community urine samples were analyzed from adult male patients who attended the Laboratorio Hidalgo, Buenos Aires, Argentina. Antimicrobial susceptibility testing was performed by the Kirby-Bauer disc diffusion method. Isolates resistant to third generation cephalosporin were tested for extended-spectrum beta-lactamase (ESBL) production using the double-disk synergy test.
Of the 3,105 urine samples analyzed, 791 (25.5%) had significant bacteriuria. The frequency of positive urine cultures increased significantly with patient age. Escherichia coli was isolated most frequently (47.3%), followed by Enterococcus faecalis (13.6%), and Klebsiella pneumoniae (11.9%). Gram-negative organisms represented 78.8% of urinary pathogens. The highest activities against Gram-negative bacteria were found with imipenem (99.0%), amikacin (98.1%), ertapenem (94.2%), fosfomycin (90.7%), and piperacillin-tazobactam (90.1%). The frequencies of ESBLs among E. coli, K. pneumoniae, and P. mirabilis were 15.2 %, 22.3%, and 8%, respectively. Fosfomycin, piperacillin-tazobactam, and nitrofurantoin were most effective against Gram-positive organisms.
Fosfomycin may be an excellent option for cystitis treatment in patients without risk factors, whereas piperacillin-tazobactam is preferred for the treatment of parenchymatous UTIs, complicated UTIs, and UTIs associated with risk factors. To ensure the optimal selection of antibiotics, physicians should have access to up-to-date information about the local prevalence of antimicrobial resistance.
了解尿路病原体的病因及抗菌药物敏感性模式对于确定最佳治疗方案至关重要。本研究旨在确定从成年男性门诊患者中分离出的细菌菌株的分布及抗生素敏感性模式。
2012年11月至2013年4月期间,对阿根廷布宜诺斯艾利斯伊达尔戈实验室成年男性患者的3105份社区尿液样本进行了分析。采用 Kirby-Bauer 纸片扩散法进行抗菌药物敏感性试验。对耐第三代头孢菌素的分离株使用双纸片协同试验检测超广谱β-内酰胺酶(ESBL)的产生情况。
在分析的3105份尿液样本中,791份(25.5%)有显著菌尿。尿培养阳性率随患者年龄显著增加。最常分离出的是大肠埃希菌(47.3%),其次是粪肠球菌(13.6%)和肺炎克雷伯菌(11.9%)。革兰阴性菌占尿路病原体的78.8%。对革兰阴性菌活性最高的药物是亚胺培南(99.0%)、阿米卡星(98.1%)、厄他培南(94.2%)、磷霉素(90.7%)和哌拉西林-他唑巴坦(90.1%)。大肠埃希菌、肺炎克雷伯菌和奇异变形杆菌中ESBLs的发生率分别为15.2%、22.3%和8%。磷霉素、哌拉西林-他唑巴坦和呋喃妥因对革兰阳性菌最有效。
对于无危险因素的膀胱炎患者,磷霉素可能是一个很好的治疗选择,而哌拉西林-他唑巴坦则更适合治疗实质性尿路感染、复杂性尿路感染以及伴有危险因素的尿路感染。为确保抗生素的最佳选择,医生应获取有关当地抗菌药物耐药性流行情况的最新信息。